journal article·2017-02Open access

Toxic effects of metal oxide nanoparticles and their underlying mechanisms

Yanli Wang, Lin Ding, Chenjie Yao, Chenchen Li, Xiaojun Xing, Yanan Huang, Tianjiao Gu, Minghong Wu

Science China Materials· Volume 60· Issue 2

Abstract

Nanomaterials have attracted considerable interest owing to their unique physicochemical properties. The wide application of nanomaterials has raised many concerns about their potential risks to human health and the environment. Metal oxide nanoparticles (MONPs), one of the main members of nanomaterials, have been applied in various fields, such as food, medicine, cosmetics, and sensors. This review highlights the bio-toxic effects of widely applied MONPs and their underlying mechanisms. Two main underlying toxicity mechanisms, reactive oxygen species (ROS)- and non-ROS-mediated toxicities, of MONPs have been widely accepted. ROS activates oxidative stress, which leads to lipid peroxidation and cell membrane damage. In addition, ROS can trigger the apoptotic pathway by activating caspase-9 and -3. Non-ROS-mediated toxicity mechanism includes the effect of released ions, excessive accumulation of NPs on the cell surface, and combination of NPs with specific death receptors. Furthermore, the combined toxicity evaluation of some MONPs is also discussed. Toxicity may dramatically change when nanomaterials are used in a combined system because the characteristics of NPs that play a key role in their toxicity such as size, surface properties, and chemical nature in the complex system are different from the pristine NPs.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev, 2012, 41: 2256–228210.1039/C1CS15166E ↗
2. Wu QS, Liu JW, Wang GS, et al. A surfactant-free route to synthesize BaxSr1−x TiO3 nanoparticles at room temperature, their dielectric and microwave absorption properties. Sci China Mater, 2016, 59: 609–617
3. Arvizo RR, Bhattacharyya S, Kudgus RA, et al. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev, 2012, 41: 294310.1039/c2cs15355f ↗
4. Llevot A, Astruc D. Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer. Chem Soc Rev, 2012, 41: 242–25710.1039/C1CS15080D ↗
5. Sun Z, Liao T, Kou L. Strategies for designing metal oxide nanostructures. Sci China Mater, 2017, 60: 1–2410.1007/s40843-016-5117-0 ↗
6. Rana S, Bajaj A, Mout R, et al. Monolayer coated gold nanoparticles for delivery applications. Adv DrugDeliver Rev, 2012, 64: 200–21610.1016/j.addr.2011.08.006 ↗
7. Lin X, Zuo YY, Gu N. Shape affects the interactions of nanoparticles with pulmonary surfactant. Sci China Mater, 2015, 58: 28–3710.1007/s40843-014-0018-5 ↗
8. Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol, 2003, 21: 1166–117010.1038/nbt875 ↗
9. Zhao Y, Xing G, Chai Z. Nanotoxicology: are carbon nanotubes safe? Nat Nanotech, 2008, 3: 191–19210.1038/nnano.2008.77 ↗
10. Hoet PHM, Nemmar A, Nemery B. Health impact of nanomaterials? Nat Biotechnol, 2004, 22: 1910.1038/nbt0104-19 ↗
11. Service RF. Nanomaterials show signs of toxicity. Science, 2003, 300: 24310.1126/science.300.5617.243a ↗
12. Chen L, Remondetto GE, Subirade M. Food protein-based materials as nutraceutical delivery systems. Trends Food Sci Tech, 2006, 17: 272–28310.1016/j.tifs.2005.12.011 ↗
13. Donaldson K, Tran L, Jimenez LA, et al. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol, 2005, 2: 1010.1186/1743-8977-2-10 ↗
14. Cortie MB, McDonagh AM. Synthesis and optical properties of hybrid and alloy plasmonic nanoparticles. Chem Rev, 2011, 111: 3713–373510.1021/cr1002529 ↗
15. Yang F, Li M, Cui H, et al. Altering the response of intracellular reactive oxygen to magnetic nanoparticles using ultrasound and microbubbles. Sci China Mater, 2015, 58: 467–48010.1007/s40843-015-0059-9 ↗
16. Koeneman BA, Zhang Y, Westerhoff P, et al. Toxicity and cellular responses of intestinal cells exposed to titanium dioxide. Cell Biol Toxicol, 2010, 26: 225–23810.1007/s10565-009-9132-z ↗
17. Jani PU, McCarthy DE, Florence AT. Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int J Pharm, 1994, 105: 157–16810.1016/0378-5173(94)90461-8 ↗
18. Liu X, Zhang J, Tang S, et al. Growth enhancing effect of LBLassembled magnetic nanoparticles on primary bone marrow cells. Sci China Mater, 2016, 59: 901–91010.1007/s40843-016-5104-9 ↗
19. Ning Z, Sillanpää M, Pakbin P, et al. Field evaluation of a new particle concentrator-electrostatic precipitator system for measuring chemical and toxicological properties of particulate matter. Part Fibre Toxicol, 2008, 5: 1510.1186/1743-8977-5-15 ↗
20. Wiesner MR, Lowry GV, Alvarez P, et al. Assessing the risks of manufactured nanomaterials. Environ Sci Technol, 2006, 40: 4336–434510.1021/es062726m ↗
21. Chen JL, Fayerweather WE. Epidemiologic study of workers exposed to titanium dioxide. J Occupational Environ Med, 1988, 30: 937–94210.1097/00043764-198812000-00011 ↗
22. Ghosh M, Chakraborty A, Mukherjee A. Cytotoxic, genotoxic and the hemolytic effect of titanium dioxide (TiO2) nanoparticles on human erythrocyte and lymphocyte cells in vitro. J Appl Toxicol, 2013, 33: 1097–111010.1002/jat.2863 ↗
23. Zhang J, Li S, Yang P, et al. Deposition of transparent TiO2 nanotubes-films via electrophoretic technique for photovoltaic applications. Sci China Mater, 2015, 58: 785–79010.1007/s40843-015-0085-7 ↗
24. Magdolenova Z, Bilaničová D, Pojana G, et al. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J Environ Monit, 2012, 14: 455–46410.1039/c2em10746e ↗
25. Thomas KV, Farkas J, Farmen E, et al. Effects of dispersed aggregates of carbon and titanium dioxide engineered nanoparticles on rainbow trout hepatocytes. J Toxicol Environ Health A, 2011, 74: 466–47710.1080/15287394.2011.550557 ↗
26. Sha BY, Gao W, Wang SQ, et al. Cytotoxicity of titanium dioxide nanoparticles differs in four liver cells from human and rat. Composites Part B-Eng, 2011, 42: 2136–214410.1016/j.compositesb.2011.05.009 ↗
27. Pujalté I, Passagne I, Brouillaud B, et al. Cytotoxicity and oxidative stress induced by differentmetallic nanoparticles on human kidney cells. Part Fibre Toxicol, 2011, 8: 1010.1186/1743-8977-8-10 ↗
28. Botelho MC, Costa C, Silva S, et al. Effects of titanium dioxide nanoparticles in human gastric epithelial cells in vitro. Biomed Pharmacother, 2014, 68: 59–6410.1016/j.biopha.2013.08.006 ↗
29. Butler KS, Casey BJ, Garborcauskas GVM, et al. Assessment of titanium dioxide nanoparticle effects in bacteria: association, uptake, mutagenicity, co-mutagenicity and DNA repair inhibition. Mutation Res/Genet Toxicol Environ Mutagenesis, 2014, 768: 14–2210.1016/j.mrgentox.2014.04.008 ↗
30. Valdiglesias V, Costa C, Sharma V, et al. Comparative study on effects of two different types of titanium dioxide nanoparticles on human neuronal cells. Food Chem Toxicol, 2013, 57: 352–36110.1016/j.fct.2013.04.010 ↗
31. Wang Y, Yao C, Li C, et al. Excess titaniumdioxide nanoparticles on the cell surface induce cytotoxicity by hindering ion exchange and disrupting exocytosis processes. Nanoscale, 2015, 7: 13105–1311510.1039/C5NR03269E ↗
32. Yin Y, Zhu WW, Guo LP, et al. RGDC functionalized titanium dioxide nanoparticles induce less damage to plasmid DNA but higher cytotoxicity to HeLa cells. J Phys Chem B, 2013, 117: 125–13110.1021/jp3092804 ↗
33. Venkatasubbu GD, Ramasamy S, Avadhani GS, et al. Size-mediated cytotoxicity of nanocrystalline titanium dioxide, pure and zincdoped hydroxyapatite nanoparticles in human hepatoma cells. J Nanopart Res, 2012, 14: 81910.1007/s11051-012-0819-3 ↗
34. Liang G, Pu Y, Yin L, et al. Influence of different sizes of titanium dioxide nanoparticles on hepatic and renal functions in rats with correlation to oxidative stress. J Toxicol Environ Health A, 2009, 72: 740–74510.1080/15287390902841516 ↗
35. Zhang Y, Yu W, Jiang X, et al. Analysis of the cytotoxicity of differentially sized titanium dioxide nanoparticles inmurineMC3T3-E1 preosteoblasts. J Mater Sci-Mater Med, 2011, 22: 1933–194510.1007/s10856-011-4375-7 ↗
36. Xiong S, George S, Yu H, et al. Size influences the cytotoxicity of poly (lactic-co-glycolic acid) (PLGA) and titanium dioxide (TiO2) nanoparticles. Arch Toxicol, 2013, 87: 1075–108610.1007/s00204-012-0938-8 ↗
37. Wang Y, Sui K, Fang J, et al. Cytotoxicity evaluation and subcellular location of titanium dioxide nanotubes. Appl Biochem Biotechnol, 2013, 171: 1568–157710.1007/s12010-013-0447-0 ↗
38. Wang Y, Wang J, Deng X, et al. Direct imaging of titania nanotubes located in mouse neural stem cell nuclei. Nano Res, 2009, 2: 543–55210.1007/s12274-009-9052-5 ↗
39. Wang Y, Wu Q, Sui K, et al. A quantitative study of exocytosis of titanium dioxide nanoparticles from neural stem cells. Nanoscale, 2013, 5: 4737–474310.1039/c3nr00796k ↗
40. Tsuji JS, Maynard AD, Howard PC, et al. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol Sci, 2005, 89: 42–5010.1093/toxsci/kfi339 ↗
41. Lademann J, Weigmann HJ, Rickmeyer C, et al. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Physiol, 1999, 12: 247–25610.1159/000066249 ↗
42. Wu J, Liu W, Xue C, et al. Toxicity and penetration of TiO2 nanoparticles in hairlessmice and porcine skin after subchronic dermal exposure. Toxicol Lett, 2009, 191: 1–810.1016/j.toxlet.2009.05.020 ↗
43. Hagens WI, Oomen AG, de Jong WH, et al. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharm, 2007, 49: 217–22910.1016/j.yrtph.2007.07.006 ↗
44. Namavar F, Cheung CL, Sabirianov RF, et al. Lotus effect in engineered zirconia. Nano Lett, 2008, 8: 988–99610.1021/nl072147v ↗
45. Li J, Li Q, Xu J, et al. Comparative study on the acute pulmonary toxicity induced by 3 and 20 nm TiO2 primary particles in mice. Environ Toxicol Pharmacol, 2007, 24: 239–24410.1016/j.etap.2007.06.004 ↗
46. Liu R, Yin L, Pu Y, et al. Pulmonary toxicity induced by three forms of titanium dioxide nanoparticles via intra-tracheal instillation in rats. Prog Nat Sci, 2009, 19: 573–57910.1016/j.pnsc.2008.06.020 ↗
47. Hamilton RF, Wu N, Porter D, et al. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol, 2009, 6: 3510.1186/1743-8977-6-35 ↗
48. Chen XX, Cheng B, Yang YX, et al. Characterization and preliminary toxicity assay of nano-titanium dioxide additive in sugarcoated chewing gum. Small, 2013, 9: 1765–177410.1002/smll.201201506 ↗
49. Wang Y, Chen Z, Ba T, et al. Susceptibility of young and adult rats to the oral toxicity of titanium dioxide nanoparticles. Small, 2013, 9: 1742–175210.1002/smll.201201185 ↗
50. Fang J, Yuan LL, Yao CJ, et al. Biodistribution and toxicity study of titanium dioxide nanoparticles of different sizes after intravenous injection in mice. Adv Mater Res, 2014, 998–999: 196–199
51. Yao C, Li C, Ding L, et al. Effects of exposure routes on the biodistribution and toxicity of titanium dioxide nanoparticles inmice. J Nanosci Nanotechnol, 2016, 16: 7110–711710.1166/jnn.2016.11349 ↗
52. Zhang J, Lang HP, Huber F, et al. Rapid and label-free nanomechanical detection of biomarker transcripts in human RNA. Nat Nanotech, 2006, 1: 214–22010.1038/nnano.2006.134 ↗
53. Dunphy Guzmán KA, Taylor MR, Banfield JF. Environmental risks of nanotechnology: National Nanotechnology Initiative Funding, 2000−2004. Environ Sci Technol, 2006, 40: 1401–140710.1021/es0515708 ↗
54. He W, Wu H, Wamer WG, et al. Unraveling the enhanced photocatalytic activity and phototoxicity of ZnO/metal hybrid nanostructures from generation of reactive oxygen species and charge carriers. ACS Appl Mater Interfaces, 2014, 6: 15527–1553510.1021/am5043005 ↗
55. Wissing SA, Müller RH. Solid lipid nanoparticles (SLN)—a novel carrier for UV blockers. Die Pharmazie, 2001, 56: 783–786
56. Zhang Y, Kang Z, Yan X, et al. ZnO nanostructures in enzyme biosensors. Sci China Mater, 2015, 58: 60–7610.1007/s40843-015-0017-6 ↗
57. Chen S, Lou Z, Chen D, et al. Highly flexible strain sensor based on ZnO nanowires and P(VDF-TrFE) fibers for wearable electronic device. Sci China Mater, 2016, 59: 173–18110.1007/s40843-016-0128-8 ↗
58. Wang Y, Yuan L, Yao C, et al. A combined toxicity study of zinc oxide nanoparticles and vitamin C in food additives. Nanoscale, 2014, 6: 15333–1534210.1039/C4NR05480F ↗
59. Mortimer M, Kasemets K, Kahru A. Toxicity of ZnO and CuO nanoparticles to ciliated protozoa Tetrahymena thermophila. Toxicol, 2010, 269: 182–18910.1016/j.tox.2009.07.007 ↗
60. Suh KS, Lee YS, Seo SH, et al. Effect of zinc oxide nanoparticles on the function of MC3T3-E1 osteoblastic cells. Biol Trace Elem Res, 2013, 155: 287–29410.1007/s12011-013-9772-y ↗
61. Xu M, Fujita D, Kajiwara S, et al. Contribution of physicochemical characteristics of nano-oxides to cytotoxicity. Biomaterials, 2010, 31: 8022–803110.1016/j.biomaterials.2010.06.022 ↗
62. Chen R, Huo L, Shi X, et al. Endoplasmic reticulum stress induced by zinc oxide nanoparticles is an earlier biomarker for nanotoxicological evaluation. ACS Nano, 2014, 8: 2562–257410.1021/nn406184r ↗
63. Moos PJ, Chung K, Woessner D, et al. ZnO particulate matter requires cell contact for toxicity in human colon cancer cells. Chem Res Toxicol, 2010, 23: 733–73910.1021/tx900203v ↗
64. Sahu D, Kannan GM, Vijayaraghavan R. Size-dependent effect of zinc oxide on toxicity and inflammatory potential of humanmonocytes. J Toxicol Environ Health A, 2014, 77: 177–19110.1080/15287394.2013.853224 ↗
65. Yin H, Casey PS, McCall MJ. Surface modifications of ZnO nanoparticles and their cytotoxicity. J Nanosci Nanotech, 2010, 10: 7565–757010.1166/jnn.2010.2833 ↗
66. Gilbert E, Pirot F, Bertholle V, et al. Commonly used UV filter toxicity on biological functions: review of last decade studies. Int J Cosmet Sci, 2013, 35: 208–21910.1111/ics.12030 ↗
67. Cross SE, Innes B, Roberts MS, et al. Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novelmicronized zinc oxide formulation. Skin Pharmacol Physiol, 2007, 20: 148–15410.1159/000098701 ↗
68. Filipe P, Silva JN, Silva R, et al. Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol, 2009, 22: 266–27510.1159/000235554 ↗
69. Jang YS, Lee EY, Park YH, et al. The potential for skin irritation, phototoxicity, and sensitization of ZnO nanoparticles. Mol Cell Toxicol, 2012, 8: 171–17710.1007/s13273-012-0021-9 ↗
70. Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontology, 2008, 43: 370–37710.1016/j.exger.2007.10.013 ↗
71. Rincker MJ, Hill GM, Link JE, et al. Effects of dietary iron supplementation on growth performance, hematological status, and whole-body mineral concentrations of nursery pigs. J Anim Sci, 2004, 82: 3189–319710.2527/2004.82113189x ↗
72. Sharma V, Singh P, Pandey AK, et al. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutation Res-Genet Tox En, 2012, 745: 84–9110.1016/j.mrgentox.2011.12.009 ↗
73. Ko JW, Hong ET, Lee IC, et al. Evaluation of 2-week repeated oral dose toxicity of 100 nm zinc oxide nanoparticles in rats. Lab Anim Res, 2015, 31: 139–14710.5625/lar.2015.31.3.139 ↗
74. Nie Z, Wang Y, Zhang Y, et al. Multi-shelled α-Fe2O3microspheres for high-rate supercapacitors. Sci China Mater, 2016, 59: 247–25310.1007/s40843-016-5028-8 ↗
75. Li W, Feng X, Liu D, et al. In situ redox strategy for large-scale fabrication of surfactant-free M-Fe2O3 (M = Pt, Pd, Au) hybrid nanospheres. Sci China Mater, 2016, 59: 191–19910.1007/s40843-016-5038-1 ↗
76. Ling D, Hyeon T. Chemical design of biocompatible iron oxide nanoparticles for medical applications. Small, 2013, 9: 1450–146610.1002/smll.201202111 ↗
77. Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliver Rev, 2010, 62: 284–30410.1016/j.addr.2009.11.002 ↗
78. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev, 2008, 108: 2064–211010.1021/cr068445e ↗
79. Cai H, An X, Cui J, et al. Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications. ACS Appl Mater Interfaces, 2013, 5: 1722–173110.1021/am302883m ↗
80. Berry CC, Wells S, Charles S, et al. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials, 2004, 25: 5405–541310.1016/j.biomaterials.2003.12.046 ↗
81. Stroh A, Zimmer C, Gutzeit C, et al. Iron oxide particles formolecularmagnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radical Biol Med, 2004, 36: 976–98410.1016/j.freeradbiomed.2004.01.016 ↗
82. Pawelczyk E, Arbab AS, Chaudhry A, et al. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages fromlabeled stem cells: implications for cellular therapy. Stem Cells, 2008, 26: 1366–137510.1634/stemcells.2007-0707 ↗
83. Siglienti I, Bendszus M, Kleinschnitz C, et al. Cytokine profile of iron-laden macrophages: implications for cellular magnetic resonance imaging. J Neuroimmunol, 2006, 173: 166–17310.1016/j.jneuroim.2005.11.011 ↗
84. Mahmoudi M, Simchi A, Imani M, et al. An in vitro study of bare and poly(ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: a new toxicity identification procedure. Nanotechnology, 2009, 20: 22510410.1088/0957-4484/20/22/225104 ↗
85. Huang G, Diakur J, Xu Z, et al. Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. Int J Pharm, 2008, 360: 197–20310.1016/j.ijpharm.2008.04.029 ↗
86. Naqvi S, Samim M, Abdin M, et al. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomedicine, 2010, 5: 983–98910.2147/IJN.S13244 ↗
87. Kunzmann A, Andersson B, Vogt C, et al. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol, 2011, 253: 81–9310.1016/j.taap.2011.03.011 ↗
88. Karlsson HL, Cronholm P, Gustafsson J, et al. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol, 2008, 21: 1726–173210.1021/tx800064j ↗
89. Hussain SM, Hess KL, Gearhart JM, et al. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol in Vitro, 2005, 19: 975–98310.1016/j.tiv.2005.06.034 ↗
90. Hohnholt MC, Dringen R. Uptake andmetabolismof iron and iron oxide nanoparticles in brain astrocytes. Biochm Soc Trans, 2013, 41: 1588–159210.1042/BST20130114 ↗
91. Gu L, Fang RH, Sailor MJ, et al. In vivo clearance and toxicity of monodisperse iron oxide nanocrystals. ACS Nano, 2012, 6: 4947–495410.1021/nn300456z ↗
92. Zhu MT, Feng WY, Wang Y, et al. Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol Sci, 2008, 107: 342–35110.1093/toxsci/kfn245 ↗
93. Bellusci M, La Barbera A, Padella F, et al. Biodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical process. Int J Nanomed, 2014, 9: 1919–1929
94. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, 2005, 26: 3995–402110.1016/j.biomaterials.2004.10.012 ↗
95. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, et al. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev, 2012, 112: 2323–233810.1021/cr2002596 ↗
96. Zhang YQ, Dringen R, Petters C, et al. Toxicity of dimercaptosuccinate-coated and un-functionalized magnetic iron oxide nanoparticles towards aquatic organisms. Environ Sci-Nano, 2016, 3: 754–76710.1039/C5EN00222B ↗
97. Zhu MT, Feng WY, Wang B, et al. Comparative study of pulmonary responses to nano-and submicron-sized ferric oxide in rats. Toxicology, 2008, 247: 102–11110.1016/j.tox.2008.02.011 ↗
98. Di Bona KR, Xu Y, Ramirez PA, et al. Surface charge and dosage dependent potential developmental toxicity and biodistribution of iron oxide nanoparticles in pregnant CD-1 mice. Reprod Toxicol, 2014, 50: 36–4210.1016/j.reprotox.2014.09.010 ↗
99. Hanini J, Schmitt J, Kacem K, et al. Evaluation of iron oxide nanoparticle biocompatibility. Int J Nanomedicine, 2011, 6: 787–794
100. Sun T, Yan Y, Zhao Y, et al. Copper oxide nanoparticles induce autophagic cell death in A549 cells. PLoS ONE, 2012, 7: e4344210.1371/journal.pone.0043442 ↗